Pfizer CEO joins 64% of executives using AI for strategic decisions
As Pfizer’s Albert Bourla integrates AI to challenge his own views, broader industry trends show a rapid shift toward algorithmic influence in high-stakes business choices, with routine decision-making projected to nearly double by 2030.
Pfizer chief executive Albert Bourla has disclosed that he utilises artificial intelligence to challenge his own views and assist with major business decisions, a practice that aligns with a growing trend among global corporate leaders. Bourla described the technology as an additional point of view rather than a sole decision-maker, supplementing the advice he receives from trusted human advisors. He made these comments during an interview with Accenture CEO Julie Sweet for CNN’s “The 1 on 1” series, highlighting how executives are increasingly seeking diverse inputs to navigate complex strategic landscapes.
This individual adoption is supported by data from the IBM Institute for Business, which found that 64% of surveyed CEOs are comfortable using AI-generated input to make strategic choices. The integration of AI into executive workflows is not merely experimental but is becoming a standard component of corporate governance. Bourla noted that while he still relies on human judgment for high-stakes calls, he actively uses AI to identify details that his thought process might have overlooked, ensuring a more rigorous evaluation of potential outcomes.
The shift towards algorithmic assistance is further evidenced by the increasing appointment of Chief AI Officers (CAIOs). These roles are responsible for defining how AI supports a business’s mission, ensuring employee skill development, and fostering an AI-friendly culture. According to IBM data, all surveyed organisations with CAIOs reported that CEOs expect the role to gain influence by 2030, signalling a structural change in how companies manage their technological infrastructure and strategic planning.
Quantitative projections from IBM indicate a significant rise in the autonomy of AI systems within business operations. While 25% of routine, low-risk business decisions were made by AI without human intervention in 2023, this figure is projected to rise to 48% by 2030. This expansion suggests that AI is moving beyond advisory roles into operational execution, potentially reshaping the efficiency and speed of corporate decision-making processes across various sectors.
The implications for investors are substantial, as major decisions driven by AI can impact stock performance and investor sentiment. However, the direct correlation between specific AI interventions and market movements remains difficult to isolate. Unlike traditional executive hires or public announcements, AI-driven decisions often occur behind the scenes, making it challenging for market participants to gauge their immediate impact on share prices or long-term valuation metrics.
Despite the benefits, concerns remain regarding the reliability of AI as an objective advisor. Large Language Models are known to be sycophantic, often affirming what they sense the user wants to hear rather than challenging it. This raises questions about whether AI acts as a constructive counterpoint or merely reinforces existing biases. Bourla’s approach of balancing AI insights with human advice may mitigate this risk, but the potential for algorithmic echo chambers remains a consideration for corporate boards.
As companies continue to pour significant time, money, and resources into AI, its power in the business world is growing. This shift has the potential to impact many stakeholders, including investors who may not realise how deeply AI is integrated into the decision-making processes of the companies they hold. The trend is unlikely to slow down, with AI becoming an increasingly central figure in the strategic architecture of global enterprises.
